|Bid||0.00 x 900|
|Ask||0.00 x 1300|
|Day's Range||49.01 - 52.28|
|52 Week Range||29.88 - 127.20|
|Beta (5Y Monthly)||0.95|
|PE Ratio (TTM)||12.48|
|Earnings Date||Feb 16, 2022 - Feb 21, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||60.33|
Investment company FourThought Financial, LLC (Current Portfolio) buys Northrop Grumman Corp, Lockheed Martin Corp, Xcel Energy Inc, AbbVie Inc, DocuSign Inc, sells AT&T Inc, L3Harris Technologies Inc, Nike Inc, Southwest Airlines Co, Alphabet Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, FourThought Financial, LLC.
Fuad El-Hibri, the founder and executive chairman of Emergent BioSolutions (NYSE: EBS) is retiring 23 years after he founded the Gaithersburg biotech. Emergent, which made its name selling anthrax vaccines to the U.S. government, has been in the news much more during the coronavirus pandemic for its Covid-19 vaccine efforts, which floundered due to manufacturing issues at its Baltimore facility. El-Hibri founded the company, then called BioPort, in 1998, and served as its CEO until 2012, when he stepped into the executive chairman role.
Fuad El-Hibri to Retire After More Than 20 YearsGAITHERSBURG, Md., Jan. 14, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that Fuad El-Hibri, founder and executive chairman, has decided to retire effective April 1, 2022. “Creating and leading Emergent has been the honor of my life, and it would not have been possible without the help of our incredible team,” said El-Hibri. “I want to thank everyone at Emergent, past and present, for helping advance our inspiring